(NewsNation) — In a clinical trial, researchers in China say they have successfully treated a patient with late-stage type 2 diabetes using stem cell-derived islet cells transplanted into the liver.

China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication ... has gained the greenlight on the Chinese mainland. The approval was ...

a team of Chinese scientists and clinicians has reportedly cured a patient of diabetes using cell therapy for the first time. The patient, a 59-year-old man who had endured type 2 diabetes for 25 ...

Chinese scientists have developed a nanovaccine ... cancer – an invasive form that cannot be treated with hormone therapy – the nanovaccine achieved a tumour inhibition rate of 89.3 per ...